US Stock MarketDetailed Quotes

RNTX Rein Therapeutics

Watchlist
  • 1.710
  • -0.070-3.93%
Close Apr 30 16:00 ET
37.88MMarket Cap-0.49P/E (TTM)

Rein Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.54%-22.29M
53.69%-4.81M
-132.87%-3.82M
-169.22%-8.39M
-13.09%-5.27M
20.34%-19.81M
-135.68%-10.39M
76.47%-1.64M
45.19%-3.12M
40.24%-4.66M
Net income from continuing operations
-299.71%-62.88M
-458.40%-40.98M
-220.03%-5.85M
-400.39%-8.94M
-48.84%-7.11M
42.43%-15.73M
-61.40%-7.34M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
Operating gains losses
----
----
----
----
----
---36K
---10K
---42K
--0
--16K
Depreciation and amortization
-47.06%63K
--0
--0
-66.67%4K
37.21%59K
-29.59%119K
20.93%52K
-72.09%12K
-71.43%12K
4.88%43K
Change In working capital
144.82%2.41M
72.86%-964K
13,918.18%1.52M
114.03%223K
813.10%1.63M
-1,381.19%-5.38M
-1,624.27%-3.55M
98.93%-11K
-190.54%-1.59M
-118.10%-229K
-Change in prepaid assets
162.75%134K
54.86%223K
147.03%206K
-589.80%-480K
-25.10%185K
-96.84%51K
-84.78%144K
-7.09%-438K
-86.93%98K
-24.23%247K
-Change in payables and accrued expense
126.32%1.41M
102.47%90K
69.32%723K
123.95%404K
141.76%195K
-404.14%-5.36M
-225.31%-3.64M
173.37%427K
-262.84%-1.69M
-16.75%-467K
-Change in other current assets
73,133.33%2.19M
--0
--707K
--183K
5,320.83%1.3M
---3K
---27K
--0
--0
--24K
-Change in other current liabilities
452.31%229K
965.63%277K
---116K
--116K
-45.45%-48K
49.61%-65K
5.88%-32K
--0
--0
-6.45%-33K
-Change in other working capital
---1.55M
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-12.54%-22.29M
53.69%-4.81M
-132.87%-3.82M
-169.22%-8.39M
-13.09%-5.27M
20.34%-19.81M
-135.68%-10.39M
76.47%-1.64M
45.19%-3.12M
40.24%-4.66M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
-38.79%16.2M
-102.02%-96K
-87.04%542K
44.95%8.5M
-37.76%7.25M
Net PPE purchase and sale
--0
--0
----
----
----
--42K
--0
----
----
----
Net business purchase and sale
--0
----
----
----
----
---96K
----
----
----
----
Net investment purchase and sale
--0
--0
--0
--0
--0
-38.58%16.25M
--0
-88.04%500K
44.95%8.5M
-37.76%7.25M
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
-38.79%16.2M
-102.02%-96K
-87.04%542K
44.95%8.5M
-37.76%7.25M
Financing cash flow
Cash flow from continuing financing activities
12.81%17.82M
-99.99%1K
-446K
15.79M
15.79M
0
Net common stock issuance
--10.65M
--0
---292K
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
--7.17M
--1K
--7.07M
----
----
--0
--0
--0
----
----
Net other financing activities
----
----
----
----
----
--15.79M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
12.81%17.82M
-99.99%1K
---446K
----
----
--15.79M
--15.79M
--0
----
----
Net cash flow
Beginning cash position
232.21%17.34M
46.16%17.68M
66.33%21.94M
54.55%12.07M
232.21%17.34M
43.97%5.22M
148.64%12.09M
72.38%13.19M
4.47%7.81M
43.97%5.22M
Current changes in cash
-136.72%-4.47M
-190.65%-4.81M
-288.43%-4.27M
83.40%9.87M
-303.59%-5.27M
664.24%12.18M
1,394.93%5.31M
60.63%-1.1M
2,907.82%5.38M
-32.74%2.59M
Effect of exchange rate changes
--0
98.41%-1K
--0
----
----
---63K
---63K
--0
----
----
End cash Position
-25.80%12.87M
-25.80%12.87M
46.16%17.68M
66.33%21.94M
54.55%12.07M
232.21%17.34M
232.21%17.34M
148.64%12.09M
72.38%13.19M
4.47%7.81M
Free cash flow
-12.54%-22.29M
53.69%-4.81M
-132.87%-3.82M
-169.22%-8.39M
-13.09%-5.27M
20.34%-19.81M
-135.68%-10.39M
76.47%-1.64M
45.19%-3.12M
40.24%-4.66M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.54%-22.29M53.69%-4.81M-132.87%-3.82M-169.22%-8.39M-13.09%-5.27M20.34%-19.81M-135.68%-10.39M76.47%-1.64M45.19%-3.12M40.24%-4.66M
Net income from continuing operations -299.71%-62.88M-458.40%-40.98M-220.03%-5.85M-400.39%-8.94M-48.84%-7.11M42.43%-15.73M-61.40%-7.34M71.31%-1.83M77.64%-1.79M43.26%-4.78M
Operating gains losses -----------------------36K---10K---42K--0--16K
Depreciation and amortization -47.06%63K--0--0-66.67%4K37.21%59K-29.59%119K20.93%52K-72.09%12K-71.43%12K4.88%43K
Change In working capital 144.82%2.41M72.86%-964K13,918.18%1.52M114.03%223K813.10%1.63M-1,381.19%-5.38M-1,624.27%-3.55M98.93%-11K-190.54%-1.59M-118.10%-229K
-Change in prepaid assets 162.75%134K54.86%223K147.03%206K-589.80%-480K-25.10%185K-96.84%51K-84.78%144K-7.09%-438K-86.93%98K-24.23%247K
-Change in payables and accrued expense 126.32%1.41M102.47%90K69.32%723K123.95%404K141.76%195K-404.14%-5.36M-225.31%-3.64M173.37%427K-262.84%-1.69M-16.75%-467K
-Change in other current assets 73,133.33%2.19M--0--707K--183K5,320.83%1.3M---3K---27K--0--0--24K
-Change in other current liabilities 452.31%229K965.63%277K---116K--116K-45.45%-48K49.61%-65K5.88%-32K--0--0-6.45%-33K
-Change in other working capital ---1.55M------------------------------------
Cash from discontinued investing activities
Operating cash flow -12.54%-22.29M53.69%-4.81M-132.87%-3.82M-169.22%-8.39M-13.09%-5.27M20.34%-19.81M-135.68%-10.39M76.47%-1.64M45.19%-3.12M40.24%-4.66M
Investing cash flow
Cash flow from continuing investing activities 00000-38.79%16.2M-102.02%-96K-87.04%542K44.95%8.5M-37.76%7.25M
Net PPE purchase and sale --0--0--------------42K--0------------
Net business purchase and sale --0-------------------96K----------------
Net investment purchase and sale --0--0--0--0--0-38.58%16.25M--0-88.04%500K44.95%8.5M-37.76%7.25M
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0-38.79%16.2M-102.02%-96K-87.04%542K44.95%8.5M-37.76%7.25M
Financing cash flow
Cash flow from continuing financing activities 12.81%17.82M-99.99%1K-446K15.79M15.79M0
Net common stock issuance --10.65M--0---292K----------0--0--0--------
Proceeds from stock option exercised by employees --7.17M--1K--7.07M----------0--0--0--------
Net other financing activities ----------------------15.79M----------------
Cash from discontinued financing activities
Financing cash flow 12.81%17.82M-99.99%1K---446K----------15.79M--15.79M--0--------
Net cash flow
Beginning cash position 232.21%17.34M46.16%17.68M66.33%21.94M54.55%12.07M232.21%17.34M43.97%5.22M148.64%12.09M72.38%13.19M4.47%7.81M43.97%5.22M
Current changes in cash -136.72%-4.47M-190.65%-4.81M-288.43%-4.27M83.40%9.87M-303.59%-5.27M664.24%12.18M1,394.93%5.31M60.63%-1.1M2,907.82%5.38M-32.74%2.59M
Effect of exchange rate changes --098.41%-1K--0-----------63K---63K--0--------
End cash Position -25.80%12.87M-25.80%12.87M46.16%17.68M66.33%21.94M54.55%12.07M232.21%17.34M232.21%17.34M148.64%12.09M72.38%13.19M4.47%7.81M
Free cash flow -12.54%-22.29M53.69%-4.81M-132.87%-3.82M-169.22%-8.39M-13.09%-5.27M20.34%-19.81M-135.68%-10.39M76.47%-1.64M45.19%-3.12M40.24%-4.66M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Meritage Homes
MTH
68.140
KB Home
KBH
54.030
D.R. Horton
DHI
126.340
4
Adobe
ADBE
374.980
5
Lennar Corp
LEN
108.610
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Earnings Season Underway

Earnings season is here. What to know?